This report aims to provide a comprehensive presentation of the global market for GFAP Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GFAP Antibody. This report contains market size and forecasts of GFAP Antibody in global, including the following market information:
Global GFAP Antibody Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global GFAP Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Polyclonal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of GFAP Antibody include Aviva Systems Biology, Merck, FineTest, Santa Cruz Biotechnology, Miltenyi Biotec, Sino Biological, Enzo Life Sciences, Proteintech and Atlas Antibodies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the GFAP Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GFAP Antibody Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global GFAP Antibody Market Segment Percentages, by Type, 2022 (%)
Polyclonal
Monoclonal
Global GFAP Antibody Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global GFAP Antibody Market Segment Percentages, by Application, 2022 (%)
Immunofluorescence
Western Blot
Immunohistochemistry Frozen
Immunohistochemistry Paraffin
Others
Global GFAP Antibody Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global GFAP Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GFAP Antibody revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies GFAP Antibody revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aviva Systems Biology
Merck
FineTest
Santa Cruz Biotechnology
Miltenyi Biotec
Sino Biological
Enzo Life Sciences
Proteintech
Atlas Antibodies
GeneTex
Synaptic Systems
Hytest
ProSci
EnCor Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of GFAP Antibody, market overview.
Chapter 2: Global GFAP Antibody market size in revenue.
Chapter 3: Detailed analysis of GFAP Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of GFAP Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 GFAP Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global GFAP Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global GFAP Antibody Overall Market Size
2.1 Global GFAP Antibody Market Size: 2022 VS 2032
2.2 Global GFAP Antibody Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top GFAP Antibody Players in Global Market
3.2 Top Global GFAP Antibody Companies Ranked by Revenue
3.3 Global GFAP Antibody Revenue by Companies
3.4 Top 3 and Top 5 GFAP Antibody Companies in Global Market, by Revenue in 2022
3.5 Global Companies GFAP Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 GFAP Antibody Players in Global Market
3.6.1 List of Global Tier 1 GFAP Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 GFAP Antibody Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global GFAP Antibody Market Size Markets, 2022 & 2032
4.1.2 Polyclonal
4.1.3 Monoclonal
4.2 By Type - Global GFAP Antibody Revenue & Forecasts
4.2.1 By Type - Global GFAP Antibody Revenue, 2018-2023
4.2.2 By Type - Global GFAP Antibody Revenue, 2024-2032
4.2.3 By Type - Global GFAP Antibody Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global GFAP Antibody Market Size, 2022 & 2032
5.1.2 Immunofluorescence
5.1.3 Western Blot
5.1.4 Immunohistochemistry Frozen
5.1.5 Immunohistochemistry Paraffin
5.1.6 Others
5.2 By Application - Global GFAP Antibody Revenue & Forecasts
5.2.1 By Application - Global GFAP Antibody Revenue, 2018-2023
5.2.2 By Application - Global GFAP Antibody Revenue, 2024-2032
5.2.3 By Application - Global GFAP Antibody Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global GFAP Antibody Market Size, 2022 & 2032
6.2 By Region - Global GFAP Antibody Revenue & Forecasts
6.2.1 By Region - Global GFAP Antibody Revenue, 2018-2023
6.2.2 By Region - Global GFAP Antibody Revenue, 2024-2032
6.2.3 By Region - Global GFAP Antibody Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America GFAP Antibody Revenue, 2018-2032
6.3.2 US GFAP Antibody Market Size, 2018-2032
6.3.3 Canada GFAP Antibody Market Size, 2018-2032
6.3.4 Mexico GFAP Antibody Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe GFAP Antibody Revenue, 2018-2032
6.4.2 Germany GFAP Antibody Market Size, 2018-2032
6.4.3 France GFAP Antibody Market Size, 2018-2032
6.4.4 U.K. GFAP Antibody Market Size, 2018-2032
6.4.5 Italy GFAP Antibody Market Size, 2018-2032
6.4.6 Russia GFAP Antibody Market Size, 2018-2032
6.4.7 Nordic Countries GFAP Antibody Market Size, 2018-2032
6.4.8 Benelux GFAP Antibody Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia GFAP Antibody Revenue, 2018-2032
6.5.2 China GFAP Antibody Market Size, 2018-2032
6.5.3 Japan GFAP Antibody Market Size, 2018-2032
6.5.4 South Korea GFAP Antibody Market Size, 2018-2032
6.5.5 Southeast Asia GFAP Antibody Market Size, 2018-2032
6.5.6 India GFAP Antibody Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America GFAP Antibody Revenue, 2018-2032
6.6.2 Brazil GFAP Antibody Market Size, 2018-2032
6.6.3 Argentina GFAP Antibody Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa GFAP Antibody Revenue, 2018-2032
6.7.2 Turkey GFAP Antibody Market Size, 2018-2032
6.7.3 Israel GFAP Antibody Market Size, 2018-2032
6.7.4 Saudi Arabia GFAP Antibody Market Size, 2018-2032
6.7.5 UAE GFAP Antibody Market Size, 2018-2032
7 GFAP Antibody Companies Profiles
7.1 Aviva Systems Biology
7.1.1 Aviva Systems Biology Company Summary
7.1.2 Aviva Systems Biology Business Overview
7.1.3 Aviva Systems Biology GFAP Antibody Major Product Offerings
7.1.4 Aviva Systems Biology GFAP Antibody Revenue in Global Market (2018-2023)
7.1.5 Aviva Systems Biology Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck GFAP Antibody Major Product Offerings
7.2.4 Merck GFAP Antibody Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 FineTest
7.3.1 FineTest Company Summary
7.3.2 FineTest Business Overview
7.3.3 FineTest GFAP Antibody Major Product Offerings
7.3.4 FineTest GFAP Antibody Revenue in Global Market (2018-2023)
7.3.5 FineTest Key News & Latest Developments
7.4 Santa Cruz Biotechnology
7.4.1 Santa Cruz Biotechnology Company Summary
7.4.2 Santa Cruz Biotechnology Business Overview
7.4.3 Santa Cruz Biotechnology GFAP Antibody Major Product Offerings
7.4.4 Santa Cruz Biotechnology GFAP Antibody Revenue in Global Market (2018-2023)
7.4.5 Santa Cruz Biotechnology Key News & Latest Developments
7.5 Miltenyi Biotec
7.5.1 Miltenyi Biotec Company Summary
7.5.2 Miltenyi Biotec Business Overview
7.5.3 Miltenyi Biotec GFAP Antibody Major Product Offerings
7.5.4 Miltenyi Biotec GFAP Antibody Revenue in Global Market (2018-2023)
7.5.5 Miltenyi Biotec Key News & Latest Developments
7.6 Sino Biological
7.6.1 Sino Biological Company Summary
7.6.2 Sino Biological Business Overview
7.6.3 Sino Biological GFAP Antibody Major Product Offerings
7.6.4 Sino Biological GFAP Antibody Revenue in Global Market (2018-2023)
7.6.5 Sino Biological Key News & Latest Developments
7.7 Enzo Life Sciences
7.7.1 Enzo Life Sciences Company Summary
7.7.2 Enzo Life Sciences Business Overview
7.7.3 Enzo Life Sciences GFAP Antibody Major Product Offerings
7.7.4 Enzo Life Sciences GFAP Antibody Revenue in Global Market (2018-2023)
7.7.5 Enzo Life Sciences Key News & Latest Developments
7.8 Proteintech
7.8.1 Proteintech Company Summary
7.8.2 Proteintech Business Overview
7.8.3 Proteintech GFAP Antibody Major Product Offerings
7.8.4 Proteintech GFAP Antibody Revenue in Global Market (2018-2023)
7.8.5 Proteintech Key News & Latest Developments
7.9 Atlas Antibodies
7.9.1 Atlas Antibodies Company Summary
7.9.2 Atlas Antibodies Business Overview
7.9.3 Atlas Antibodies GFAP Antibody Major Product Offerings
7.9.4 Atlas Antibodies GFAP Antibody Revenue in Global Market (2018-2023)
7.9.5 Atlas Antibodies Key News & Latest Developments
7.10 GeneTex
7.10.1 GeneTex Company Summary
7.10.2 GeneTex Business Overview
7.10.3 GeneTex GFAP Antibody Major Product Offerings
7.10.4 GeneTex GFAP Antibody Revenue in Global Market (2018-2023)
7.10.5 GeneTex Key News & Latest Developments
7.11 Synaptic Systems
7.11.1 Synaptic Systems Company Summary
7.11.2 Synaptic Systems Business Overview
7.11.3 Synaptic Systems GFAP Antibody Major Product Offerings
7.11.4 Synaptic Systems GFAP Antibody Revenue in Global Market (2018-2023)
7.11.5 Synaptic Systems Key News & Latest Developments
7.12 Hytest
7.12.1 Hytest Company Summary
7.12.2 Hytest Business Overview
7.12.3 Hytest GFAP Antibody Major Product Offerings
7.12.4 Hytest GFAP Antibody Revenue in Global Market (2018-2023)
7.12.5 Hytest Key News & Latest Developments
7.13 ProSci
7.13.1 ProSci Company Summary
7.13.2 ProSci Business Overview
7.13.3 ProSci GFAP Antibody Major Product Offerings
7.13.4 ProSci GFAP Antibody Revenue in Global Market (2018-2023)
7.13.5 ProSci Key News & Latest Developments
7.14 EnCor Biotechnology
7.14.1 EnCor Biotechnology Company Summary
7.14.2 EnCor Biotechnology Business Overview
7.14.3 EnCor Biotechnology GFAP Antibody Major Product Offerings
7.14.4 EnCor Biotechnology GFAP Antibody Revenue in Global Market (2018-2023)
7.14.5 EnCor Biotechnology Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. GFAP Antibody Market Opportunities & Trends in Global Market
Table 2. GFAP Antibody Market Drivers in Global Market
Table 3. GFAP Antibody Market Restraints in Global Market
Table 4. Key Players of GFAP Antibody in Global Market
Table 5. Top GFAP Antibody Players in Global Market, Ranking by Revenue (2022)
Table 6. Global GFAP Antibody Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global GFAP Antibody Revenue Share by Companies, 2018-2023
Table 8. Global Companies GFAP Antibody Product Type
Table 9. List of Global Tier 1 GFAP Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 GFAP Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global GFAP Antibody Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - GFAP Antibody Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - GFAP Antibody Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global GFAP Antibody Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - GFAP Antibody Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - GFAP Antibody Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global GFAP Antibody Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global GFAP Antibody Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global GFAP Antibody Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America GFAP Antibody Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America GFAP Antibody Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe GFAP Antibody Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe GFAP Antibody Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia GFAP Antibody Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia GFAP Antibody Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America GFAP Antibody Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America GFAP Antibody Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa GFAP Antibody Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa GFAP Antibody Revenue, (US$, Mn), 2024-2032
Table 30. Aviva Systems Biology Company Summary
Table 31. Aviva Systems Biology GFAP Antibody Product Offerings
Table 32. Aviva Systems Biology GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 33. Aviva Systems Biology Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck GFAP Antibody Product Offerings
Table 36. Merck GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. FineTest Company Summary
Table 39. FineTest GFAP Antibody Product Offerings
Table 40. FineTest GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 41. FineTest Key News & Latest Developments
Table 42. Santa Cruz Biotechnology Company Summary
Table 43. Santa Cruz Biotechnology GFAP Antibody Product Offerings
Table 44. Santa Cruz Biotechnology GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 45. Santa Cruz Biotechnology Key News & Latest Developments
Table 46. Miltenyi Biotec Company Summary
Table 47. Miltenyi Biotec GFAP Antibody Product Offerings
Table 48. Miltenyi Biotec GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 49. Miltenyi Biotec Key News & Latest Developments
Table 50. Sino Biological Company Summary
Table 51. Sino Biological GFAP Antibody Product Offerings
Table 52. Sino Biological GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 53. Sino Biological Key News & Latest Developments
Table 54. Enzo Life Sciences Company Summary
Table 55. Enzo Life Sciences GFAP Antibody Product Offerings
Table 56. Enzo Life Sciences GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 57. Enzo Life Sciences Key News & Latest Developments
Table 58. Proteintech Company Summary
Table 59. Proteintech GFAP Antibody Product Offerings
Table 60. Proteintech GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 61. Proteintech Key News & Latest Developments
Table 62. Atlas Antibodies Company Summary
Table 63. Atlas Antibodies GFAP Antibody Product Offerings
Table 64. Atlas Antibodies GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 65. Atlas Antibodies Key News & Latest Developments
Table 66. GeneTex Company Summary
Table 67. GeneTex GFAP Antibody Product Offerings
Table 68. GeneTex GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 69. GeneTex Key News & Latest Developments
Table 70. Synaptic Systems Company Summary
Table 71. Synaptic Systems GFAP Antibody Product Offerings
Table 72. Synaptic Systems GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 73. Synaptic Systems Key News & Latest Developments
Table 74. Hytest Company Summary
Table 75. Hytest GFAP Antibody Product Offerings
Table 76. Hytest GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 77. Hytest Key News & Latest Developments
Table 78. ProSci Company Summary
Table 79. ProSci GFAP Antibody Product Offerings
Table 80. ProSci GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 81. ProSci Key News & Latest Developments
Table 82. EnCor Biotechnology Company Summary
Table 83. EnCor Biotechnology GFAP Antibody Product Offerings
Table 84. EnCor Biotechnology GFAP Antibody Revenue (US$, Mn) & (2018-2023)
Table 85. EnCor Biotechnology Key News & Latest Developments
List of Figures
Figure 1. GFAP Antibody Segment by Type in 2022
Figure 2. GFAP Antibody Segment by Application in 2022
Figure 3. Global GFAP Antibody Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global GFAP Antibody Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global GFAP Antibody Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by GFAP Antibody Revenue in 2022
Figure 8. By Type - Global GFAP Antibody Revenue Market Share, 2018-2032
Figure 9. By Application - Global GFAP Antibody Revenue Market Share, 2018-2032
Figure 10. By Type - Global GFAP Antibody Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global GFAP Antibody Revenue Market Share, 2018-2032
Figure 12. By Application - Global GFAP Antibody Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global GFAP Antibody Revenue Market Share, 2018-2032
Figure 14. By Region - Global GFAP Antibody Revenue Market Share, 2018-2032
Figure 15. By Country - North America GFAP Antibody Revenue Market Share, 2018-2032
Figure 16. US GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 17. Canada GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe GFAP Antibody Revenue Market Share, 2018-2032
Figure 20. Germany GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 21. France GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 23. Italy GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 24. Russia GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia GFAP Antibody Revenue Market Share, 2018-2032
Figure 28. China GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 29. Japan GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 32. India GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America GFAP Antibody Revenue Market Share, 2018-2032
Figure 34. Brazil GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa GFAP Antibody Revenue Market Share, 2018-2032
Figure 37. Turkey GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 38. Israel GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 40. UAE GFAP Antibody Revenue, (US$, Mn), 2018-2032
Figure 41. Aviva Systems Biology GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. FineTest GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Santa Cruz Biotechnology GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Miltenyi Biotec GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sino Biological GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Enzo Life Sciences GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Proteintech GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Atlas Antibodies GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GeneTex GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Synaptic Systems GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Hytest GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. ProSci GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. EnCor Biotechnology GFAP Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
